NYSE:MCKHealthcare
Should You Reassess McKesson After Its Double Digit Gains and CVS Collaboration in 2025?
If you are keeping an eye on McKesson stock these days, you are hardly alone. Whether you are a current shareholder, thinking about jumping in, or just watching for cues from one of healthcare’s giants, recent movements in MCK have definitely stirred up conversation. In the past year alone, the stock has gained nearly 24%, a run that easily outpaces the broader market and hints at serious momentum. For those with a longer view, the total return over five years has soared to more than 360%,...